5 High-Growth Biotechnology Stocks That Analysts Strongly Favor

Some investors consider the biotechnology sector as having too slow of a pay-off, in some cases taking 20 or more years to materialize. But focusing on biotechs that are projected for growth in the near term is one way biotech investors can see quicker gains. Today we focused on biotechs in this vein, by searching for those with growth on the horizon, indicated by a strong EPS rate, such as 25% and higher. Additionally, we narrowed our list of candidates by focusing on "cream-of-the-crop" companies, those that on average have scored a "Strong Buy" rating from biotech industry analysts. With these ideas in mind, we came up with an intriguing list of biotechs. Take a look to see if any of these stocks capture your interest.EPS growth (earnings per share growth) illustrates the growth of earnings per share over time. The 1-Year Expected EPS Growth Rate is an annual
... Read the rest at SeekingAlpha.com